Allogeneic tumor lysate can serve as both antigen source and protein supplementation for dendritic cell culture |
| |
Authors: | Peter Dubsky Hubert Hayden Monika Sachet Thomas Bachleitner-Hofmann Michaela Hassler Roswitha Pfragner Michael Gnant Anton Stift Josef Friedl |
| |
Institution: | 1.Department of Surgery,Medical University of Vienna,Vienna,Austria;2.Department of Pathophysiology,Medical University of Graz,Graz,Austria |
| |
Abstract: | BACKGROUND: Recent preclinical and clinical evidence suggests the use of allogeneic tumor as a source of antigen for DC-based immunotherapy against cancer. We hypothesized that addition of allogeneic tumor lysate to monocyte-derived DC culture could serve a dual purpose: (1) antigen source and (2) protein supplementation of DC culture media. Protein supplementation whether of known origin (human serum/plasma, fetal bovine serum, human serum albumin) or undeclared origin ("serum-free" media) is a source of variability and bias. We addressed the question whether protein supplementation can be omitted in the presence of allogeneic tumor lysate. MATERIALS AND METHODS: Human DC cultured in the presence of lysate from medullary thyroid carcinoma (MTC) cell line SHER-I (TuLy-DC) and DC pulsed with the same lysate but cultured in the presence of FBS (FBS-DC) were assessed for morphology, phenotype, maturation and functional properties. RESULTS: In comparison of FBS-DC/TuLy-DC no significant differences in morphology, phenotype and maturation could be detected. Both culture conditions produced CD1a(high), CD14(low) DC with high expression of costimulatory molecules and CD83 upon stimulation. TuLy-DC gave significantly better yields and produced more IL12p70. DC showed high (allo)stimulatory capacity toward T-cells. TuLy-DC induced more intracellular IFNgamma in CD8+T-cells of vaccinated MTC patients. Both types of DC induced killing of SHER-I after short in vitro restimulation. Tumor lysate from SHER-I can substitute for further protein supplementation in DC culture. Allogeneic tumor lysates should be taken into consideration as both source of antigen and protein supplementation in monocyte-derived DC culture. |
| |
Keywords: | Dendritic cells Immunotherapy Tumor lysate Medullary thyroid carcinoma DC culture |
本文献已被 PubMed SpringerLink 等数据库收录! |
|